Blood circulation promotion in TCM theory (null)

Molecular Classification

Other

Other Names

Promote blood circulation" (TCM principle), Activate blood circulation and remove blood stasis, Blood stasis resolution therapy, Invigorating blood/qi, Blood stasis syndrome treatment

Disease Roles

Cardiovascular diseaseDiabetes mellitus and microvascular complicationsChronic kidney disease

Blood circulation promotion in TCM theory Overview

This entry does not correspond to a defined molecule, receptor, enzyme, transporter, or gene, but rather refers to a therapeutic principle central to Traditional Chinese Medicine (TCM) aiming to remedy "blood stasis" by promoting blood circulation. TCM achieves these effects through herbal medicines, acupuncture, and other therapies, targeting system-level processes such as improved hemodynamics, microvascular integrity, and balanced platelet activity. These interventions have been used in the context of cardiovascular diseases, diabetes complications, chronic kidney disease, and cancer, but mapping this principle to a canonical molecular target is inappropriate. Numerous herbs and compounds are cited as "blood circulation promoting" but should be referenced individually if a molecular target is needed. Modern drugs like aspirin and heparin overlap with some mechanistic underpinnings in TCM.

Mechanism of Action

Improve microcirculation, inhibit platelet aggregation, modulate TXA₂/PGI₂ balance, protect vascular endothelium, inhibit Na⁺/K⁺-ATPase (leading to increased myocardial contractility), reduce oxidative stress, and regulate lipid metabolism

Biological Functions

Other (system-level effects: improve microcirculation, modulate hemodynamics, reduce platelet aggregation, regulate endothelial function)

Disease Associations

Cardiovascular disease

Diabetes mellitus and microvascular complications

Chronic kidney disease

Cancer (especially tumor stasis)

Safety Considerations

Hemorrhagic risk (if combined with anticoagulants/antiplatelet drugs)
herb-drug interactions
syndrome specificity (TCM diagnosis required for proper use)
variable evidence quality and lack of standardization among herbal preparations

Interacting Drugs

TCM compounds and formulas, such as Salvia miltiorrhiza, Panax notoginseng, Angelica sinensis, Typhae pollen, Ligusticum wallichii, Carthamus tinctorius, Caulis Spatholobi, leech extracts, and formula preparations like Guanxin II, Taohongsiwu Decoction, and Honghua injection, as well as modern drugs with similar mechanistic overlaps like heparin and aspirin

Associated Biomarkers

Biomarker
TXA₂/PGI₂ ratio
plasma TXB₂
6-keto-PGF1α
markers of endothelial function
platelet aggregation measures